Plasma glucosylceramide levels are regulated by ATP10D and are not involved in Parkinson's disease pathogenesis.
Emma N. Somerville, Alva James, Christian Beetz, Robert Schwieger, Gal Barrel, Krishna Kumar Kandaswamy, Marius I. Iurascu, Peter O. Bauer, Michael Ta, Hirotaka Iwaki, Konstantin A. Senkevich, Eric Yu, Roy N. Alcalay, Ziv Gan‐Or
The paper investigates the role of ATP10D and GlcCer in Parkinson's disease, finding ATP10D regulates plasma GlcCer levels but is not involved in PD pathogenesis.
Annals of Neurology · Mar 1, 2025Peer-reviewedGenetic & Genomic Medicine